2017-02-13,Aviragen Therapeutics Announces Top-Line Results From Phase 2b SPIRITUS Trial Of Vapendavir
2017-02-02,Aviragen Therapeutics Reports Second Quarter Fiscal Year 2017 Financial Results
2017-02-01,Aviragen Therapeutics Announces Top-Line Results From Phase 2a RSV Challenge Study Of BTA585
2017-01-26,Aviragen Therapeutics To Host Conference Call To Report Second Quarter Fiscal Year 2017 Financial Results On February 2, 2017
2016-11-09,Aviragen Therapeutics To Present At Stifel 2016 Healthcare Conference
2016-11-03,Aviragen Therapeutics Reports First Quarter Fiscal Year 2017 Financial Results
2016-10-27,Aviragen Therapeutics To Host Conference Call To Report First Quarter Fiscal Year 2017 Financial Results On November 3, 2016
2016-10-10,Aviragen Therapeutics To Host KOL Meeting On HRV Infections On October 13, 2016 In New York
2016-09-14,Aviragen Therapeutics Reports Fourth Quarter And Fiscal Year 2016 Financial Results
2016-09-13,Aviragen Therapeutics Announces Rescheduled Date And Time Of Fourth Quarter And Fiscal Year 2016 Financial Results On September 14, 2016
2016-09-07,Aviragen Therapeutics To Present At Upcoming Investor Conferences
2016-09-06,Aviragen Therapeutics Announces Inducement Grant For New Employees
2016-09-06,Aviragen Therapeutics Announces Schedule Change For Fourth Quarter And Fiscal Year End 2016 Financial Results Conference Call And Webcast
2016-09-01,Aviragen Therapeutics To Host Conference Call To Report Fourth Quarter And Fiscal Year 2016 Financial Results On September 8, 2016
2016-07-12,Aviragen Therapeutics Resumes Enrollment In Phase 2a RSV Challenge Trial
2016-07-05,Aviragen Therapeutics And Georgia State University Research Foundation Enter Exclusive License And Sponsored Research Agreement To Develop Novel Antiviral Therapies
2016-07-01,Aviragen Therapeutics Announces Inducement Grant For New Employee
2016-06-28,Aviragen Therapeutics Announces The Appointment Of Jonas Niaura As Vice President, Corporate Development And Strategy
2016-05-26,Aviragen Therapeutics Provides Update On Phase 2a Trial Of BTA585 For The Treatment Of RSV Infections
2016-05-05,Aviragen Therapeutics Reports Third Quarter Fiscal Year 2016 Financial Results
2016-04-28,Aviragen Therapeutics To Host Conference Call To Report Third Quarter Fiscal Year 2016 Financial Results On May 5, 2016
2016-04-25,Aviragen Therapeutics Completes Royalty Deal With HealthCare Royalty Partners For Proceeds Of $20 Million
2016-04-14,Aviragen Therapeutics To Participate In FBR & Co. Healthcare Series Focused On Infectious Diseases
2001-12-06,Who Wins, Who Loses in the MedImmune-Aviron Deal
2001-12-04,Biotech Bonus
2001-12-03,MedImmune Fattens Its Drug Pipeline by Buying Aviron
2001-12-03,MedImmune to Buy Aviron for $1.5 Billion
2001-09-04,Aviron Says Flu Drug Won't Be as Late as Feared
2001-08-15,Aviron Could Make a Healthy Comeback
2001-03-15,The Daily Interview: GenomicsFund.com's Steve Newby
,
,
,
,
,
